1. European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC. (11th September 2017) Authors: Nast, A.; Spuls, P.I.; van der Kraaij, G.; Gisondi, P.; Paul, C.; Ormerod, A.D.; Saiag, P.; Smith, C.H.; Dauden, E.; de Jong, E.M.; Feist, E.; Jobling, R.; Maccarone, M.; Mrowietz, U.; Papp, K.A.; Reich, K.; Rosumeck, S.; Talme, T.; Thio, H.B.; van de Kerkhof, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 12(2017) Page Start: 1951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Methods report: European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC. (24th September 2017) Authors: Dressler, C.; Rosumeck, S.; Werner, R.N.; van der Kraaij, G.; van Lumig, P.; Wakkee, M.; Spuls, P.; Nast, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 12(2017) Page Start: 1964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗